Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Missale

Showing results (41-50 of 111) with videos related to

Pageof 12
Sort By:
Gastroenterology|December 31, 2003
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infectionTeresa Pollicino, Giovanni Squadrito, Giovanni Cerenzia, et al.
JTO Clinical and Research Reports|July 23, 2025
<i>BRAF</i> Fusion as Resistance Mechanism to Osimertinib in <i>EGFR</i>-Mutated NSCLC: A Case Report and Review of LiteratureMarianna Peroni, Alessandro Leonetti, Roberta Minari, et al.
Gastroenterology|August 30, 2012
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCVPaola Fisicaro, Caterina Valdatta, Marco Massari, et al.
Heliyon|December 18, 2023
High CD49a+ NK cell infiltrate is associated with poor clinical outcomes in Hepatocellular CarcinomaAlessandra Zecca, Valeria Barili, Carolina Boni, et al.
Frontiers in Immunology|June 2, 2020
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic ApproachesPaola Fisicaro, Valeria Barili, Marzia Rossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2008
Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancerAntonino Musolino, Nadia Naldi, Beatrice Bortesi, et al.
Frontiers in Immunology|June 9, 2022
Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver CancerAlessandra Zecca, Valeria Barili, Andrea Olivani, et al.
Frontiers in Oncology|October 19, 2020
Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell LinesGraziana Digiacomo, Claudia Fumarola, Silvia La Monica, et al.
Journal of Virology|February 9, 2007
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infectionCarolina Boni, Paola Fisicaro, Caterina Valdatta, et al.
European Journal of Immunology|October 2, 2004
Parenteral exposure to high HIV viremia leads to virus-specific T cell priming without evidence of infectionGabriele Missale, Laura Papagno, Amalia Penna, et al.
Pageof 12

Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
Gastroenterology|December 31, 2003
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infectionTeresa Pollicino, Giovanni Squadrito, Giovanni Cerenzia, et al.
JTO Clinical and Research Reports|July 23, 2025
<i>BRAF</i> Fusion as Resistance Mechanism to Osimertinib in <i>EGFR</i>-Mutated NSCLC: A Case Report and Review of LiteratureMarianna Peroni, Alessandro Leonetti, Roberta Minari, et al.
Gastroenterology|August 30, 2012
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCVPaola Fisicaro, Caterina Valdatta, Marco Massari, et al.
Heliyon|December 18, 2023
High CD49a+ NK cell infiltrate is associated with poor clinical outcomes in Hepatocellular CarcinomaAlessandra Zecca, Valeria Barili, Carolina Boni, et al.
Frontiers in Immunology|June 2, 2020
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic ApproachesPaola Fisicaro, Valeria Barili, Marzia Rossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2008
Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancerAntonino Musolino, Nadia Naldi, Beatrice Bortesi, et al.
Frontiers in Immunology|June 9, 2022
Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver CancerAlessandra Zecca, Valeria Barili, Andrea Olivani, et al.
Frontiers in Oncology|October 19, 2020
Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell LinesGraziana Digiacomo, Claudia Fumarola, Silvia La Monica, et al.
Journal of Virology|February 9, 2007
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infectionCarolina Boni, Paola Fisicaro, Caterina Valdatta, et al.
European Journal of Immunology|October 2, 2004
Parenteral exposure to high HIV viremia leads to virus-specific T cell priming without evidence of infectionGabriele Missale, Laura Papagno, Amalia Penna, et al.
Pageof 12